Constellation Pharmaceuticals Inc

Type: Company
Name: Constellation Pharmaceuticals Inc
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Report Published: "Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014"

New Pharmaceuticals research report from Global Markets Direct is now available from Boston, MA -- (ReleaseWire) -- 09/05/2014 -- Global Markets Direct's, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014', provides an overview of the Diffuse ... [Published Digital Journal - Sep 05 2014]
First reported May 22 2014 - Updated May 22 2014 - 1 reports

Nurix launches with Series B

Third Rock Ventures and The Column Group have backed the launch of Nurix with a $25.1 million Series B financing. Nurix develops therapies that modulate the ubiquitin proteasome system. PRESS RELEASE Third Rock Ventures and The Column Group ... [Published PE Hub Blog - May 22 2014]

More Content

All (2) | News (1) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Report Published: "Diffuse Large B-Cell Lymphom... [Published Digital Journal - Sep 05 2014]
Nurix launches with Series B [Published PE Hub Blog - May 22 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Nurix launches with Series B [Published PE Hub Blog - May 22 2014]
Third Rock Ventures and The Column Group have backed the launch of Nurix with a $25.1 million Series B financing. Nurix develops therapies that modulate the ubiquitin proteasome system. PRESS RELEASE Third Rock Ventures and The Column Group ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.